42 related articles for article (PubMed ID: 2720723)
1. NPH human insulin: does it work in a once-a-day regimen?
Gadia M; Sosenko JM; Salzman R; Lauritano AA; Haycock P
Clin Ther; 1989; 11(1):120-8. PubMed ID: 2720723
[TBL] [Abstract][Full Text] [Related]
2. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
3. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes.
Haak T; Tiengo A; Draeger E; Suntum M; Waldhäusl W
Diabetes Obes Metab; 2005 Jan; 7(1):56-64. PubMed ID: 15642076
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy.
Yokoyama H; Tada J; Kamikawa F; Kanno S; Yokota Y; Kuramitsu M
Diabetes Res Clin Pract; 2006 Jul; 73(1):35-40. PubMed ID: 16513202
[TBL] [Abstract][Full Text] [Related]
5. Insulin antibodies in non-insulin-dependent diabetes mellitus: effect of treatment with semisynthetic human insulin.
Lauritano AA; Clements RS; Bell D
Clin Ther; 1989; 11(2):268-77. PubMed ID: 2660998
[TBL] [Abstract][Full Text] [Related]
6. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
[TBL] [Abstract][Full Text] [Related]
7. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
[TBL] [Abstract][Full Text] [Related]
8. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
9. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
10. Rapid decrease of insulin-specific IgG antibody levels in insulin-dependent patients transferred to semi-synthetic human insulin.
Raskin P; Etzwiler DD; Davidson JK; Nolte M; Stephens JW; MacGillivray M; Lauritano AA
Diabetes Res; 1987 Nov; 6(3):123-8. PubMed ID: 3325217
[TBL] [Abstract][Full Text] [Related]
11. [Are there problems in changing diabetic patients from animal to human insulin?].
Fankhauser S; von Rohr E
Ther Umsch; 1990 Jan; 47(1):41-8. PubMed ID: 2408181
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fixed-ratio versus variable-ratio regular and NPH semisynthetic human insulin in insulin-requiring diabetic patients.
Khachadurian AK; Davidson JA; Braunstein S; Redmond G; Greenfield M; Lauritano AA; Haycock P
Clin Ther; 1989; 11(4):485-94. PubMed ID: 2673516
[TBL] [Abstract][Full Text] [Related]
13. Dosage accuracy of self-mixed vs premixed insulin.
Bell DS; Clements RS; Perentesis G; Roddam R; Wagenknecht L
Arch Intern Med; 1991 Nov; 151(11):2265-9. PubMed ID: 1953232
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients.
Kølendorf K; Bojsen J; Deckert T
Horm Metab Res; 1983 Jun; 15(6):274-8. PubMed ID: 6409773
[TBL] [Abstract][Full Text] [Related]
15. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
Yanagisawa K
Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
[TBL] [Abstract][Full Text] [Related]
16. Use of a premixed insulin regimen (Novolin 70/30) to replace self-mixed insulin regimens.
Aronoff S; Goldberg R; Kumar D; Lichtenstein E; Schwartz S; Sosenko J
Clin Ther; 1994; 16(1):41-9. PubMed ID: 8205600
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of highly purified porcine and human insulins in diabetic patients with high titers of insulin antibody.
Lam HC; Ho LT; Tang KT; Wang LM; Kwok CF; Liu YF; Hsiao LJ; Li SH
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):346-51. PubMed ID: 2677227
[TBL] [Abstract][Full Text] [Related]
18. Chronic urticaria from isophane insulin therapy; sensitivity associated with noninsulin components in commercial preparations.
Shore RN; Shelley WB; Kyle GC
Arch Dermatol; 1975 Jan; 111(1):94-7. PubMed ID: 1119830
[TBL] [Abstract][Full Text] [Related]
19. Transfer of patients with diabetes from semisynthetic human insulin to human insulin prepared by recombinant DNA technology using baker's yeast: a double-blind, randomized study.
Davidson JA; Ramirez LC; Raskin P; Selam JL
Clin Ther; 1991; 13(5):557-68. PubMed ID: 1799913
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of s.c. Semitard MC, human NPH ge, Rapitard MC and human NPH 30:70 ge insulin in healthy, non-diabetic subjects.
Luzio SD; George L; Beck P; Chester P; Owens DR
Eur J Intern Med; 2003 Mar; 14(2):107-112. PubMed ID: 12719028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
